Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Short-chain fatty acids (SCFAs) are the main products of dietary fiber fermentation and are believed to drive the fiber-related prevention of the metabolic syndrome. Here we show that dietary SCFAs induce a peroxisome proliferator–activated receptor-γ (PPARγ)–dependent switch from lipid synthesis to utilization. Dietary SCFA supplementation prevented and reversed high-fat diet–induced metabolic abnormalities in mice by decreasing PPARγ expression and activity. This increased the expression of mitochondrial uncoupling protein 2 and raised the AMP-to-ATP ratio, thereby stimulating oxidative metabolism in liver and adipose tissue via AMPK. The SCFA-induced reduction in body weight and stimulation of insulin sensitivity were absent in mice with adipose-specific disruption of PPARγ. Similarly, SCFA-induced reduction of hepatic steatosis was absent in mice lacking hepatic PPARγ. These results demonstrate that adipose and hepatic PPARγ are critical mediators of the beneficial effects of SCFAs on the metabolic syndrome, with clearly distinct and complementary roles. Our findings indicate that SCFAs may be used therapeutically as cheap and selective PPARγ modulators.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Animal studies suggest that SCFAs have an important role in the prevention and treatment of obesity-associated insulin resistance (89, 114, 191, 192).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [191]
In the citing paper
“SCFAs are also energy substrates for numerous tissue types, including the colon [227], adipose [228] and muscle tissues [224]”
From The athletic gut microbiota (2020) · cites this paper as [228]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Self-citationHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“The main products of intestinal fermentation of dietary fibers are short-chain fatty acids (SCFAs), of which acetate, propionate, and butyrate are the most abundant (6).”
BackgroundTopping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Energy contributions of volatile fatty acids from the gastrointestinal tract in various species
Bergman, E. N. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.567 · Cited by 2,750
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409 · cited 1×
“The longer butyrate is more selective for GPR41, the shorter acetate is more selective for GPR43, and propionate binds to both receptors (12,13).”
BackgroundButyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204 · cited 2×
“It is likely that a common mechanism may involve AMPK because acetate and butyrate have been shown to increase energy expenditure by activating AMPK in liver and muscle tissue (15,18), whereas propionate activates AMPK in colon cancer cells and reduces lipid synthesis in isolated rat hepatocytes (19,20).”
BackgroundResultMicrobiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2014) · Cell · doi:10.1016/j.cell.2013.12.016 · Cited by 2,200
Cholesterol-lowering effects of dietary fiber: a meta-analysis
Brown, L., Rosner, B., Willett, W. W., & Sacks, F. M. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.30 · Cited by 1,857
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., et al. (2010) · Nature · doi:10.1038/nature08778 · Cited by 1,687
Cited by
Items 201–300 of 1,000
Liu, J., Hao, W., He, Z., Kwek, E., Zhu, H., Ma, N., Ma, K. Y., & Chen, Z. (2021) · European Journal of Nutrition · doi:10.1007/s00394-020-02446-3 · Cited by 98
Fang, H., Lacerda, R. R. E., Barra, N. G., Zada, D. K., Robin, N., Mehra, A., & Schertzer, J. D. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae025 · Cited by 97
Effects of Saponins on Lipid Metabolism: The Gut–Liver Axis Plays a Key Role
Cao, S., Liu, M., Han, Y., Li, S., Zhu, X., Li, D., Shi, Y., & Liu, B. (2024) · Nutrients · doi:10.3390/nu16101514 · Cited by 96
Impact of dietary fiber and fat on gut microbiota re-modeling and metabolic health
Benítez-Páez, A., del Pulgar, E. M. G., Kjølbæk, L., Brahe, L. K., Astrup, A., Larsen, L., & Sanz, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.11.001 · Cited by 68
Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology
May, K. S., & den Hartigh, L. J. (2023) · Nutrients · doi:10.3390/nu15020272 · Cited by 95
Zhang, M., Zhu, J., Zhang, X., Zhao, D., Ma, Y., Li, D., Ho, C., & Huang, Q. (2020) · Food & Function · doi:10.1039/c9fo02907a · Cited by 95
A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD
Sofi, M. H., Wu, Y., Ticer, T., Schutt, S., Bastian, D., Choi, H.-J., Tian, L., Mealer, C., Liu, C., Westwater, C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.136841 · Cited by 94
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Liu, M., Nieuwdorp, M., de Vos, W. M., & Rampanelli, E. (2022) · Metabolites · doi:10.3390/metabo12090834 · Cited by 94
Gut Microbiota as an Endocrine Organ: Unveiling Its Role in Human Physiology and Health
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Applied Sciences · doi:10.3390/app14209383 · Cited by 94
Gut microbiome and lipid metabolism: from associations to mechanisms
Wang, Z., Koonen, D., Hofker, M., & Fu, J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000308 · Cited by 93
Jiao, A., Yu, B., He, J., Yu, J., Zheng, P., Luo, Y., Luo, J., Mao, X., & Chen, D. (2020) · Food & Function · doi:10.1039/c9fo02585e · Cited by 93
Epigenetic regulation of energy metabolism in obesity
Gao, W., Liu, J.-L., Lu, X., & Yang, Q. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab043 · Cited by 92
Gut and obesity/metabolic disease: Focus on microbiota metabolites
Lin, K., Zhu, L., & Yang, L. (2022) · MedComm · doi:10.1002/mco2.171 · Cited by 92
The Metabolic Role and Therapeutic Potential of the Microbiome
Olofsson, L. E., & Bäckhed, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac004 · Cited by 92
Date Palm Fruit (Phoenix dactylifera): Effects on Vascular Health and Future Research Directions
Al-Dashti, Y. A., Holt, R. R., Keen, C. L., & Hackman, R. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094665 · Cited by 92
Zietek, T., Giesbertz, P., Ewers, M., Reichart, F., Weinmüller, M., Urbauer, E., Haller, D., Demir, I. E., Ceyhan, G. O., Kessler, H., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.577656 · Cited by 91
Qiu, Z., Qiao, Y., Zhang, B., Sun‐Waterhouse, D., & Zheng, Z. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12972 · Cited by 91
Obesity and Asthma: Microbiome–Metabolome Interactions
Shore, S. A., & Cho, Y. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0052ps · Cited by 90
Unger, A. L., Torres-Gonzalez, M., & Kraft, J. (2019) · Nutrients · doi:10.3390/nu11092200 · Cited by 89
Metabolic and functional interplay between gut microbiota and fat-soluble vitamins
Stacchiotti, V., Rezzi, S., Eggersdorfer, M. L., & Galli, F. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1793728 · Cited by 89
Münte, E., & Hartmann, P. (2025) · Biomolecules · doi:10.3390/biom15040469 · Cited by 89
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Jennison, E., & Byrne, C. D. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0129 · Cited by 88
Kundi, Z. M., Lee, J. C., Pihlajamäki, J., Chan, C. B., Leung, K. S., So, S. S. Y., Nordlund, E., Kolehmainen, M., & El-Nezami, H. S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900580 · Cited by 88
Microbiota and Obesity: Where Are We Now?
Ballini, A., Scacco, S., Boccellino, M., Santacroce, L., & Arrigoni, R. (2020) · Biology · doi:10.3390/biology9120415 · Cited by 88
The health benefits of dietary short-chain fatty acids in metabolic diseases
Tao, Z., & Wang, Y. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2297811 · Cited by 88
Lu, Y., Fan, C., Liang, A., Fan, X., Wang, R., Li, P., & Qi, K. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001526 · Cited by 87
Yan, S., Shi, R., Li, L., Ma, S., Zhang, H., Jin, Y., Wang, J., Pan, J., Wang, Q., Jin, X., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900521 · Cited by 87
iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies
Palasantzas, V. E. J. M., Tamargo-Rubio, I., Le, K., Slager, J., Wijmenga, C., Jonkers, I. H., Kumar, V., Fu, J., & Withoff, S. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.01.002 · Cited by 86
Laiglesia, L. M., Lorente-Cebrián, S., Prieto-Hontoria, P. L., Fernández-Galilea, M., Ribeiro, S. M. R., Sáinz, N., Martínez, J. A., & Moreno-Aliaga, M. J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.019 · Cited by 85
den Hartigh, L. J., Gao, Z., Goodspeed, L., Wang, S., Das, A. K., Burant, C., Chait, A., & Blaser, M. J. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy011 · Cited by 85
Li, J., Pang, B., Shao, D., Jiang, C., Hu, X., & Shi, J. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.069 · Cited by 85
Butyrate and obesity: Current research status and future prospect
Peng, K., Dong, W., Luo, T., Tang, H., Zhu, W., Huang, Y., & Yang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1098881 · Cited by 85
Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis
Farzi, A., Hassan, A. M., Zenz, G., & Holzer, P. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.003 · Cited by 85
Jayakumar, S., & Loomba, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 84
Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
Scapaticci, S., D’Adamo, E., Mohn, A., Chiarelli, F., & Giannini, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639548 · Cited by 84
Macronutrient Determinants of Obesity, Insulin Resistance and Metabolic Health
Wali, J. A., Solon‐Biet, S. M., Freire, T., & Brandon, A. E. (2021) · Biology · doi:10.3390/biology10040336 · Cited by 84
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
Kalkan, H., Pagano, E., Paris, D., Panza, E., Cuozzo, M., Moriello, C., Piscitelli, F., Abolghasemi, A., Gazzerro, E., Silvestri, C., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216225 · Cited by 85
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 84
Soderborg, T. K., Borengasser, S. J., Barbour, L. A., & Friedman, J. E. (2016) · Diabetologia · doi:10.1007/s00125-016-3880-0 · Cited by 83
Bluemel, S., Williams, B., Knight, R., & Schnabl, B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2016 · Cited by 83
Raza, G. S., Putaala, H., Hibberd, A. A., Alhoniemi, E., Tiihonen, K., Mäkelä, K. A., & Herzig, K.-H. (2017) · Scientific Reports · doi:10.1038/s41598-017-05259-3 · Cited by 83
Potential mediators linking gut bacteria to metabolic health: a critical view
Janssen, A. W. F., & Kersten, S. (2017) · The Journal of Physiology · doi:10.1113/jp272476 · Cited by 82
Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., & Fu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519925 · Cited by 82
Impact of gut microbiota on gut‐distal autoimmunity: a focus on T cells
Sprouse, M. L., Bates, N. A., Felix, K. M., & Wu, H.-J. J. (2019) · Immunology · doi:10.1111/imm.13037 · Cited by 57
Wang, Z., Liu, J., Li, F., Ma, S., Zhao, L., Ge, P., Wen, H., Zhang, Y., Liu, X., Luo, Y., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03664-22 · Cited by 81
Yu, Y., Ding, Y., Wang, S., & Jiang, L. (2025) · Metabolites · doi:10.3390/metabo15060397 · Cited by 81
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., & Lonardo, A. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0306-9 · Cited by 80
Schutte, S., Esser, D., Hoevenaars, F. P. M., Hooiveld, G. J. E. J., Priebe, M. G., Vonk, R. J., Wopereis, S., & Afman, L. A. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy204 · Cited by 79
Tea Polysaccharides as Potential Therapeutic Options for Metabolic Diseases
Chen, G., Chen, R., Chen, D., Ye, H., Hu, B., Zeng, X., & Liu, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05338 · Cited by 78
Liu, Z., Zhao, J., Sun, R., Wang, M., Wang, K., Li, Y., Shang, H., Hou, J., & Jiang, Z. (2022) · Food & Function · doi:10.1039/d1fo04316a · Cited by 78
Gut-microbiota derived bioactive metabolites and their functions in host physiology
Debnath, N., Kumar, R., Kumar, A., Mehta, P. K., & Yadav, A. K. (2021) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2021.1989847 · Cited by 77
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 77
Włodarczyk, M., & Śliżewska, K. (2021) · Nutrients · doi:10.3390/nu13113808 · Cited by 77
Chen, K., Wang, H., Yang, X., Tang, C., Hu, G., & Gao, Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107483 · Cited by 77
Canfora, E. E., & Blaak, E. E. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000408 · Cited by 76
Hepatic Macrophage as a Key Player in Fatty Liver Disease
Xu, L., Liu, W., Bai, F., Xu, Y., Liang, X., Ma, C., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708978 · Cited by 76
The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders
Islam, M. R., Arthur, S., Haynes, J., Butts, M. R., Nepal, N., & Sundaram, U. (2022) · Nutrients · doi:10.3390/nu14030624 · Cited by 76
Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 76
Luo, J., Qi, J., Wang, W., Luo, Z., Liu, L., Zhang, G., Zhou, Q., Liu, J., & Peng, X. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02434 · Cited by 76
Wu, G., Shi, Y., Han, L., Feng, C., Ge, Y., Yu, Y., Xue Ming, T. A. N. G., Cheng, X., Sun, J., & Le, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c02965 · Cited by 76
Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases
Wu, D., Wang, H., Xie, L., & Hu, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.908868 · Cited by 75
Local and systemic effects of microbiome‐derived metabolites
Spivak, I., Fluhr, L., & Elinav, E. (2022) · EMBO Reports · doi:10.15252/embr.202255664 · Cited by 75
Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites
Zhang, W., Dong, X. Y., & Huang, R. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01096-3 · Cited by 75
The interplay between herbal medicines and gut microbiota in metabolic diseases
Wang, L., Gou, X., Ding, Y., Liu, J., Wang, Y., Wang, Y., Zhang, J., Du, L., Peng, W., & Fan, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1105405 · Cited by 76
Inflammation in MASLD progression and cancer
Kim, Y. S., Park, Y., Rho, H., Yao, T., Gao, B., & Hwang, S. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101414 · Cited by 75
Nihei, N., Okamoto, H., Furune, T., Ikuta, N., Sasaki, K., Rimbach, G. H., Yoshikawa, Y., & Terao, K. (2018) · BioFactors · doi:10.1002/biof.1429 · Cited by 74
A metagenome-wide association study of gut microbiome and visceral fat accumulation
Nie, X., Chen, J., Ma, X., Ni, Y., Shen, Y., Yu, H., Panagiotou, G., & Bao, Y. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.026 · Cited by 74
Flavonoids, gut microbiota, and host lipid metabolism
Zhou, M., Ma, J., Kang, M., Tang, W., Xia, S., Yin, J., & Yin, Y. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202300065 · Cited by 73
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 72
Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
Flaig, B., Garza, R., Singh, B., Hamamah, S., & Covașă, M. (2023) · Nutrients · doi:10.3390/nu15010228 · Cited by 72
The human microbiome and metabolomics: Current concepts and applications
Daliri, E. B., Wei, S., Oh, D., & Lee, B. H. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1220913 · Cited by 72
From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Marzullo, P., Renzo, L. D., Pugliese, G., Siena, M. D., Barrea, L., Muscogiuri, G., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0017-1 · Cited by 72
Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota
Wisniewski, P. J., Dowden, R. A., & Campbell, S. C. (2019) · Nutrients · doi:10.3390/nu11010117 · Cited by 71
Short-chain fatty acids: Important components of the gut-brain axis against AD
Huang, Y., Wang, Y. F., Miao, J., Zheng, R. F., & Li, J. Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116601 · Cited by 70
The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Hliwa, A., Ramos‐Molina, B., Łaski, D., Mika, A., & Śledziński, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136900 · Cited by 70
Gut microbiota and its metabolites: Bridge of dietary nutrients and obesity-related diseases
Zhou, M., Johnston, L. J., Wu, C., & Ma, X. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1986466 · Cited by 70
Short-chain fatty acids are potential goalkeepers of atherosclerosis
Feng, Y., & Xu, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271001 · Cited by 70
Eussen, S. J. P. M., van Dongen, M. C. J. M., Wijckmans, N., den Biggelaar, L., Oude Elferink, S. J. W. H., Singh-Povel, C. M., Schram, M. T., Sep, S. J. S., van der Kallen, C. J., Koster, A., et al. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516000313 · Cited by 69
Recent Advances in Psoriasis Research; the Clue to Mysterious Relation to Gut Microbiome
Komine, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072582 · Cited by 69
Zheng, M., Yang, X., Wu, Q., Gong, Y., Pang, N., Ge, X., Nagaratnam, N., Jiang, P., Zhou, M., Hu, T., et al. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200597 · Cited by 69
Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axis
Li, C., Yao, J., Yang, C., Yu, S., Yang, Z., Wang, L., Li, S., & He, N. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01554-5 · Cited by 69
Vázquez‐Moreno, M. A., Pérez‐Herrera, A., Locia‐Morales, D., Dizzell, S. E., Meyre, D., Stearns, J. C., & Cruz, M. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12748 · Cited by 69
Li, Y., Bai, D., Lu, Y., Chen, J., Yang, H., Mu, Y., Xu, J., Huang, X., & Li, L. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.130 · Cited by 68
Gut microbiota is a potential goalkeeper of dyslipidemia
Lei, L., Zhao, N., Zhang, L., Chen, J., Liu, X., & Piao, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950826 · Cited by 68
Wang, Z., Zeng, M., Wang, Z., Qin, F., Chen, J., & He, Z. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00751 · Cited by 67
Yadav, S., Dwivedi, A., Tripathi, A., & Tripathi, A. K. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.007 · Cited by 67
Takai, A., Kikuchi, K., Ichimura‐Shimizu, M., Tsuneyama, K., Moritoki, Y., Matsumoto, K., Tsunashima, H., Onda, T., Kuniyoshi, N., Nariyama, T., et al. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01194-2 · Cited by 67
Gao, H., Shu, Q., Chen, J., Fan, K., Xu, P., Zhou, Q., Li, C., & Zheng, H. (2019) · mSystems · doi:10.1128/msystems.00048-19 · Cited by 66
Ferulic acid mediates prebiotic responses of cereal-derived arabinoxylans on host health
Zhang, Z., Yang, P., & Zhao, J. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.08.004 · Cited by 66
Shi, J., Ma, D., Gao, S., Long, F., Wang, X., Pu, X., Cannon, R. D., & Han, T.-L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1219763 · Cited by 66
He, B., & Moreau, R. F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.002 · Cited by 66
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Mandala, A., Janssen, R. C., Palle, S. K., Short, K. R., & Friedman, J. E. (2020) · Nutrients · doi:10.3390/nu12103166 · Cited by 66
Liu, H., Zhu, H., Xia, H., Yang, X., Yang, L., Wang, S., Wen, J., & Sun, G. (2020) · Food Research International · doi:10.1016/j.foodres.2020.110078 · Cited by 66
Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
Martínez-López, Y. E., Esquivel-Hernandez, D. A., Sánchez-Castañeda, J. P., Neri-Rosario, D., Guardado‐Mendoza, R., & Reséndis-Antonio, O. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111952 · Cited by 65
Short-chain fatty acids in fetal development and metabolism
Qin, X., Zhang, M., Chen, S., Tang, Y., Cui, J., & Ding, G. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.11.014 · Cited by 65
Rampanelli, E., Romp, N., Troise, A. D., Ananthasabesan, J., Wu, H., Gül, I. S., Pascale, S. D., Scaloni, A., Bäckhed, F., Fogliano, V., et al. (2025) · Microbiome · doi:10.1186/s40168-024-02002-9 · Cited by 65
The microbiome-adipose tissue axis in systemic metabolism
Lundgren, P., & Thaiss, C. A. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2019 · Cited by 65
Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis
Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 65
Xia, T., He, W., Luo, Z., Wang, K., & Tan, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132256 · Cited by 64
Metadata
- Authors
- den Besten, G., Bleeker, A., Gerding, A., van Eunen, K., Havinga, R., van Dijk, T. H., Oosterveer, M. H., Jonker, J. W., Groen, A. K., Reijngoud, D.-J., & Bakker, B. M.
- Affiliations
- Center for Liver, Digestive and Metabolic Diseases, Department of Pediatrics and Systems Biology, Center for Energy Metabolism and Ageing, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- University Medical Center Groningen (NL)
- Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- Corresponding author
- Bakker, Barbara M.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-02-18
- Volume
- 64
- Issue
- 7
- Pages
- 2398-2408
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1986142882
- Semantic Scholar
- 709a79725a30b02e3818835d35b75f1eff0ea518
- Cited by
- 1,125
- References
- 57
- Citations by year
- 2026: 76 · 2025: 159 · 2024: 140 · 2023: 147 · 2022: 137 · 2021: 110 · 2020: 116 · 2019: 67 · 2018: 67 · 2017: 42 · 2016: 51 · 2015: 12
- FWCI
- 24.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Netherlands Organization for Scientific Research (VIDI grant 016.126.338)
- Netherlands Consortium for Systems Biology (91108004)
- Dutch Diabetes Foundation (2012.00.1537)
- Human Frontier Science Program (CDA00013/2011-C)
- European Research Council (IRG-277169)
- Dutch Digestive Foundation (WO 11-67)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- short-chain fatty acids, PPARγ, high-fat diet-induced obesity, lipogenesis, fat oxidation, AMPK, mitochondrial uncoupling protein 2, hepatic steatosis, insulin sensitivity, metabolic syndrome, dietary fiber fermentation, adipose tissue, liver, PPARγ modulators
- MeSH terms
- Uncoupling Protein 2, Adenosine Triphosphate, Adipose Tissue, Animals, Fatty Acids, Volatile, Insulin Resistance, Ion Channels, Liver, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Mitochondrial Proteins, PPAR gamma, Lipogenesis, Mice, AMP-Activated Protein Kinases, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.